Energetic stability states in mast cell activation syndrome: operationalizing reserve, pressure, and threshold collapse.

Mast cell activation syndrome (MCAS) is characterized by pronounced heterogeneity, fluctuating severity, delayed post-perturbation crashes analogous to those documented in post-exertional malaise, and highly variable clinical trajectories that are poorly explained by mediator-centric diagnostic approaches. Patients with similar symptom profiles or laboratory findings often follow divergent courses, while resting biomarkers frequently fail to correlate with functional capacity or prognosis. Beyond serving as markers of activation, mast-cell mediators influence neural, vascular, epithelial, immune, and autonomic systems, providing a biologically plausible mechanism through which local perturbations may propagate into multisystem instability. Building on a pressure-reserve framework of energetic constraint, this paper proposes a stability-state classification framework for interpreting system behavior and identifying operating regimes. Four operational stability classifications are proposed-recovery-capable, plateau, slow drift, and crash-prone-based on the relationship between energetic reserve and reactive pressure, modulated by the degree of multisystem synchronization. Recovery-capable, plateau, and slow-drift classifications are conceptual regions along a continuous fragility axis, whereas crash-prone behavior is proposed as a threshold-crossing regime characterized by impaired recovery dynamics, hysteresis, and increased susceptibility to instability. Three complementary stability axes are introduced: energetic reserve, dominant pressure domain (dominant ingress), and synchronization. Together, these axes generate characteristic classification signatures that remain observable despite overlapping mediator profiles and fluctuating baseline values. This framework reframes MCAS as a disorder of state-dependent instability rather than mediator burden alone, provides a structured means to interpret heterogeneity, stratify patients prognostically, and track trajectory over time, and offers a foundation for longitudinal monitoring and future validation studies grounded in system dynamics rather than isolated biomarkers.